Ingersoll Rand to Acquire ILC Dover From New Mountain Capital

March 25, 2024

Ingersoll Rand has entered into an agreement to acquire ILC Dover (“ILC”) from New Mountain Capital for an upfront cash purchase price of about $2.325 billion, plus an earnout tied to 2024 operating efficiency metrics. The deal will create a life sciences platform within Ingersoll Rand’s P&ST segment, combining ILC with Ingersoll Rand’s life science-focused brands.

Buyers
Ingersoll Rand Inc.
Targets
ILC Dover
Sellers
New Mountain Capital, LLC
Industry
Medical Devices
Location
United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.